Treasury's New Biotech Restrictions Could Hurt U.S. Security

The Trump administration just proposed sweeping new restrictions on American investments in China's biotechnology sector. The rules, issued under the Comprehensive Outbound Investment National Security Act, or COINS, are intended to prevent U.S. capital and expertise from strengthening a strategic competitor.